Cite
APA Citation
Fehmi, J., Jon Walters, R., Lavin, T., Keh, R., Rossor, A. M., Munteanu, T., Delanty, N., Roberts, R., Baumer, D., & Rinaldi, S. (2022). igG1 pan-neurofascin antibodies define a severe and frequently fatal GBS-like neuropathy which responds to rituximab. Journal of neurology, neurosurgery and psychiatry, 93(6), A1. http://access.bl.uk/ark:/81055/vdc_100158620343.0x00005b